The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence

被引:0
|
作者
Avramenko, N. V. [1 ,2 ]
Kabachenko, O. V. [2 ]
Barkovskyi, D. Ye. [2 ]
Sierykh, K. V. [2 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Zaporizhia, Ukraine
[2] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Dept Obstet Gynecol & Reprod Med, Zaporizhia, Ukraine
关键词
obesity; metabolic syndrome; polycystic ovary syndrome; adolescence; diagnosis; treatment; prevention; ASSOCIATIONS; MANAGEMENT; OBESITY; HEALTH; RISK;
D O I
10.14739/2310-1210.2023.3.251479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary -de-pendent pathology. One of the major consequences of weight problems is metabolic syndrome (MS). There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension). Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome ty-pical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia). First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 50 条
  • [21] Polycystic ovary syndrome update in adolescence
    Hassan, Areej
    Gordon, Catherine M.
    CURRENT OPINION IN PEDIATRICS, 2007, 19 (04) : 389 - 397
  • [22] The pathogenetic role of thrombophilia in women with polycystic ovary syndrome and metabolic syndrome
    Pshenichnikova, T. B.
    Perederyeva, E. B.
    Makatsariya, A. D.
    THROMBOSIS RESEARCH, 2007, 119 : S114 - S114
  • [23] Is there a polycystic ovary syndrome without metabolic syndrome?
    Janssen, O. E.
    Hahn, S.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (02) : 95 - 96
  • [24] Metabolic syndrome in patients with the polycystic ovary syndrome
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 559 - 568
  • [25] The Role of Obesity in the Development of Polycystic Ovary Syndrome
    Beatriz Motta, Alicia
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (17) : 2482 - 2491
  • [26] Polycystic ovary syndrome: A component of metabolic syndrome?
    Vignesh, J. P.
    Mohan, V
    JOURNAL OF POSTGRADUATE MEDICINE, 2007, 53 (02) : 128 - 134
  • [27] Metabolic syndrome in adolescents with polycystic ovary syndrome
    Vrbikova, Jana
    Zamrazilova, Hana
    Sedlackova, Barbora
    Sanajderova, Marta
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (10) : 820 - 822
  • [28] Metabolic syndrome in women with polycystic ovary syndrome
    Chandrasekaran, Swaramya
    Sagili, Haritha
    OBSTETRICIAN & GYNAECOLOGIST, 2018, 20 (04): : 245 - 252
  • [29] Metabolic syndrome in women with polycystic ovary syndrome
    Essah, Paulina A.
    Nestler, John E.
    FERTILITY AND STERILITY, 2006, 86 : S18 - S19
  • [30] Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome
    da Silva Bouzas, Isabel Cristina
    Cader, Samaria Ali
    Leao, Lenora
    Kuschnir, Maria Cristina
    Braga, Claudia
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2014, 27 (06) : 335 - 341